Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5551 USD | +0.18% | -3.31% | -44.49% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Financials (USD)
Sales 2016 | 42.64M | Sales 2017 | 9.51M | Capitalization | 6.09M |
---|---|---|---|---|---|
Net income 2016 | -53M | Net income 2017 | -7M | EV / Sales 2016 | 0.69 x |
Net Debt 2016 | 9M | Net Debt 2017 | 10.03M | EV / Sales 2017 | 1.7 x |
P/E ratio 2016 |
-0.38
x | P/E ratio 2017 |
-0.82
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 23.58% |
1 day | +0.18% | ||
1 week | -3.31% | ||
Current month | -10.77% | ||
1 month | -10.77% | ||
3 months | -21.05% | ||
6 months | -49.99% | ||
Current year | -44.49% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
William Bossung
BRD | Director/Board Member | - | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
William Bossung
BRD | Director/Board Member | - | 18-12-02 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.5551 | +0.18% | 847 |
Delayed Quote OTC Markets, May 23, 2024 at 02:29 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-44.49% | 5.68M | |
+21.54% | 49.32B | |
+11.14% | 16.67B | |
-16.07% | 13.59B | |
-11.11% | 11.06B | |
+17.47% | 8.08B | |
-2.30% | 7.96B | |
+43.21% | 7.9B | |
+105.28% | 7.46B | |
-7.19% | 7.42B |
- Stock Market
- Equities
- YECO Stock